Sana Biotechnology
SANA
SANA
160 hedge funds and large institutions have $252M invested in Sana Biotechnology in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 41 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 164 → 160 (-4)
4.47% less ownership
Funds ownership: 70.78% → 66.32% (-4.5%)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
Holders
160
Holding in Top 10
2
Calls
$1.06M
Puts
$712K
Top Buyers
| 1 | +$3.69M | |
| 2 | +$690K | |
| 3 | +$595K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$524K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$470K |
Top Sellers
| 1 | -$6.52M | |
| 2 | -$4.84M | |
| 3 | -$2.52M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.04M |
| 5 |
Morgan Stanley
New York
|
-$1.82M |